On May 17, 2019, the first-round review meeting of the “Wu Jieping Medical Foundation–Bioray Advanced Excellence in Surgery Special Fund” was grandly held during the “12th Annual Conference of the Chinese Medical Doctor Association’s Surgeon Branch.” As the first special fund project in the field of surgery in China, this fund primarily supports research on the clinical application of biodegradable biomaterials in surgical repair, while also supporting surgeons engaged in clinical scientific research to participate in academic exchanges, education and training, and clinical research activities.
The initial startup fund reached RMB 2 million. In 2019, the program planned to support 40 clinical surgical research projects, with each project receiving a grant of RMB 50,000 over a two-year funding period. To date, a total of 40 research project applications have been received. Following preliminary review, 21 projects advanced to the first round of evaluation. At this review meeting, roadshows and evaluations were conducted for 12 of these projects.

Group Photo of Special Fund Review Experts and Participants
The meeting was chaired by Professor Shen Yingmo, a member of the Review Expert Committee of the “Wu Jieping Medical Foundation–Bohuiruijin Excellence in Surgery Special Fund.”

Shen Yingmo -
Member of the Expert Committee for the Review of the Bohuiruijin Excellence in Surgery Special Fund, Wu Jieping Medical Foundation
Deputy Director, Department of Hernia and Abdominal Wall Surgery, Beijing Chaoyang Hospital, Capital Medical University
At the outset of the meeting, Chen Linjun, Director of the Science and Technology Department of the Wu Jieping Medical Foundation, delivered opening remarks for the Special Fund Review Meeting. In his address, Director Chen emphasized that “novelty, high quality, distinctiveness, and precision” are core principles that must be adhered to in the research and application process for scientific projects. Subsequently, Professor Chen Jie, a member of the Expert Committee for the Special Fund Review, delivered his remarks. Professor Chen provided an in-depth elucidation of the scope and significance of the special fund’s support and expressed his earnest expectations for young researchers.

Chen Linjun – Director of the Science and Technology Department, Wu Jieping Medical Foundation

Chen Jie-
Member of the Review Expert Committee for the Bo Hui Rui Jin Excellence in Surgery Special Fund, Wu Jieping Medical Foundation
Director, Department of Hernia and Abdominal Wall Surgery, Beijing Chaoyang Hospital, Capital Medical University
Following the opening remarks, the roadshow officially commenced. Professor Shen Yingmo began by introducing the content and structure of the special fund project, along with the research requirements, applicant eligibility criteria, and the review process.

During the review presentations for special fund projects, applicants delivered detailed reports and analyses on research initiatives concerning biological meshes in various clinical applications. The presentations covered key aspects including research objectives and methodologies, foundational work and feasibility studies, implementation plans and performance metrics, as well as categorized budget allocations.

Qian Liyin - Dancheng County Maternal and Child Health Hospital
Tai Qinwen - Shenzhen Hospital of Southern Medical University
Jiang Zhipeng - The Sixth Affiliated Hospital of Sun Yat-sen University
Huang Jun - The Second Affiliated Hospital of Guangxi Medical University
Zheng Yansheng - Guangdong Provincial Hospital of Traditional Chinese Medicine
Chen Yikuan - The Second Affiliated Hospital of Chongqing Medical University

Yin Jie - Beijing Friendship Hospital, Capital Medical University 
Liu Jing - Beijing Chaoyang Hospital, Capital Medical University

Zhou Baojun - The Second Hospital of Hebei Medical University 
Meng Xiangzhen - Shengjing Hospital of China Medical University

Xiang Fu - The First Affiliated Hospital of Dalian Medical University 
Yin Huiming - The First Affiliated Hospital of Hunan College of Traditional Chinese Medicine
Member of the Expert Review Committee
At the conclusion of the meeting, Professor Shen Yingmo delivered a summary report on the proceedings and outcomes of the review session. Professor Shen affirmed the uniqueness and professionalism of each research project, expressing his vision and confidence in the innovative development of clinical research. During this review session, 10 research projects were approved, while 2 projects were required to undergo revisions before being resubmitted for a second round of review.
During the conference break, the China Medical Media Brand Planning Center conducted interviews with Director Chen Linjun of the Science and Technology Department of the Wu Jieping Medical Foundation, as well as five review experts. Director Chen provided a detailed introduction to the founding mission and significance of the Wu Jieping Medical Foundation, while the five review experts shared their insights on the current clinical application status and future prospects of biological patches.


Group Photo at the Interview Site
Innovation is the driving force behind industry development. With the support of the “Wu Jieping Medical Foundation–Bohuiruijin Excellence in Surgery Special Fund,” and under the rigorous oversight and guidance of expert reviewers, we anticipate that clinical surgery in China will reach new heights.